Abaxis Company Profile (NASDAQ:ABAX)

About Abaxis

Abaxis logoAbaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ABAX
  • CUSIP: 00256710
Key Metrics:
  • Previous Close: $47.04
  • 50 Day Moving Average: $51.05
  • 200 Day Moving Average: $48.40
  • 52-Week Range: $37.71 - $58.15
  • Trailing P/E Ratio: 34.21
  • Foreward P/E Ratio: 29.96
  • P/E Growth: 2.48
  • Market Cap: $1.06B
  • Outstanding Shares: 22,533,000
  • Beta: 1
  • Net Margins: 15.54%
  • Return on Equity: 12.89%
  • Return on Assets: 11.25%
  • Current Ratio: 7.11%
  • Quick Ratio: 5.95%
Additional Links:
Companies Related to Abaxis:

Analyst Ratings

Consensus Ratings for Abaxis (NASDAQ:ABAX) (?)
Ratings Breakdown: 2 Sell Ratings, 3 Hold Ratings
Consensus Rating:Hold (Score: 1.60)
Consensus Price Target: $44.67 (5.05% downside)

Analysts' Ratings History for Abaxis (NASDAQ:ABAX)
DateFirmActionRatingPrice TargetDetails
10/15/2016Canaccord GenuitySet Price TargetHold$50.00View Rating Details
8/16/2016Credit Suisse Group AGReiterated RatingSell$39.00View Rating Details
7/22/2016Feltl & Co.DowngradeHold -> SellView Rating Details
4/1/2016CL KingInitiated CoverageNeutralView Rating Details
1/29/2016Piper Jaffray Cos.Lower Price TargetNeutral$49.00 -> $45.00View Rating Details
10/21/2015Bank of America Corp.DowngradeNeutral -> Underperform$66.00 -> $39.00View Rating Details
(Data available from 10/27/2014 forward)


Earnings History for Abaxis (NASDAQ:ABAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.39$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Abaxis (NASDAQ:ABAX)
Current Year EPS Consensus Estimate: $1.35 EPS
Next Year EPS Consensus Estimate: $1.57 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.27$0.35$0.31
Q2 20162$0.39$0.40$0.40
Q3 20163$0.42$0.44$0.43
Q4 20161$0.39$0.39$0.39
Q1 20171$0.34$0.34$0.34
Q2 20171$0.34$0.34$0.34
Q3 20171$0.34$0.34$0.34
Q4 20171$0.35$0.35$0.35
Q1 20181$0.36$0.36$0.36
Q2 20181$0.40$0.40$0.40
Q3 20181$0.39$0.39$0.39
Q4 20181$0.41$0.41$0.41
(Data provided by Zacks Investment Research)


Current Dividend Information for Abaxis (NASDAQ:ABAX)
Annual Dividend:$0.48
Dividend Yield:1.02%
Payout Ratio:31.17% (Based on Trailing 12 Months of Earnings)
35.56% (Based on Current Year Consensus EPS Estimate)
30.57% (Based on Next Year Consensus EPS Estimate)

Dividend History for Abaxis (NASDAQ:ABAX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Abaxis (NASDAQ:ABAX)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 99.03%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.00View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.00View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.00View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.00View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.00View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.00View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.61View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.40View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.00View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.00View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.00View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.00View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Abaxis (NASDAQ:ABAX)
finance.yahoo.com logoEdited Transcript of ABAX earnings conference call or presentation 25-Oct-16 8:15pm GMT (NASDAQ:ABAX)
finance.yahoo.com - October 26 at 12:07 PM
capitalcube.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : October 26, 2016 (NASDAQ:ABAX)
www.capitalcube.com - October 26 at 12:07 PM
bizjournals.com logoAbaxis Reports Financial Performance for the Second Quarter of Fiscal 2017 (NASDAQ:ABAX)
www.bizjournals.com - October 25 at 8:25 PM
nasdaq.com logoAbaxis Q2 Profit Misses Estimates (NASDAQ:ABAX)
www.nasdaq.com - October 25 at 8:25 PM
sg.finance.yahoo.com logoAbaxis misses Street 2Q forecasts (NASDAQ:ABAX)
sg.finance.yahoo.com - October 25 at 8:25 PM
biz.yahoo.com logoQ2 2017 Abaxis Inc Earnings Release - After Market Close (NASDAQ:ABAX)
biz.yahoo.com - October 25 at 8:00 AM
mysmartrend.com logo19.7% Return Seen to Date on SmarTrend Abaxis Call (ABAX) (NASDAQ:ABAX)
www.mysmartrend.com - October 20 at 8:00 AM
finance.yahoo.com logoAbaxis To Report Second Quarter Fiscal Year 2017 Financial Results On Tuesday ... (NASDAQ:ABAX)
finance.yahoo.com - October 19 at 8:01 AM
publicnow.com logoAbaxis To Report Second Quarter Fiscal Year 2017 Financial Results On Tuesday, October 25, 2016 (NASDAQ:ABAX)
www.publicnow.com - October 18 at 3:11 PM
investors.com logoAbaxis, Heska Wrest Share From Idexx In Animal-Health Market (NASDAQ:ABAX)
www.investors.com - October 14 at 3:08 PM
thestreet.com logoBet on Animal Health By Investing in Idexx Laboratories, Analysts Say (NASDAQ:ABAX)
www.thestreet.com - October 14 at 3:08 PM
sbwire.com logoGlobal C-Reactive Protein Testing Market 2016: Industry Review, Research, Statistics, and Growth to 2022 (NASDAQ:ABAX)
www.sbwire.com - October 13 at 12:22 PM
News IconRecent research: Global c-reactive protein testing market 2016: cardiovascular diseases, diseases of immune system, infections (NASDAQ:ABAX)
www.whatech.com - October 13 at 12:22 PM
capitalcube.com logoABAXIS, Inc. : ABAX-US: Dividend Analysis : September 01st, 2016 (record date) : By the numbers : October 12, 2016 (NASDAQ:ABAX)
www.capitalcube.com - October 12 at 3:01 PM
mysmartrend.com logoAbaxis Shares Up 18.2% Since SmarTrend's Buy Recommendation (ABAX) (NASDAQ:ABAX)
www.mysmartrend.com - October 12 at 9:03 AM
businesswire.com logoLatin America Point Of Care (PoC) Diagnostics Market Analysis 2016-2024: Market to Reach $1.73 Billion - Research and Markets (NASDAQ:ABAX)
www.businesswire.com - October 10 at 3:01 PM
sbwire.com logoRapid Medical Diagnostic Kits Market:Awareness About Lifestyle-Related Health Conditions Augments Demand for the Market (NASDAQ:ABAX)
www.sbwire.com - October 5 at 8:00 AM
News IconVeterinary Diagnostics Market by Products & Technology - 2021 | MarketsandMarkets (NASDAQ:ABAX)
www.emailwire.com - October 5 at 8:00 AM
News IconNew report shares details about the companion animal diagnostics - global market outlook (2015-2022) (NASDAQ:ABAX)
www.whatech.com - October 5 at 8:00 AM
News IconFarm animal diagnostics - global market outlook from 2015 to 2022 just published (NASDAQ:ABAX)
www.whatech.com - October 4 at 8:00 AM
sbwire.com logoClinical Testing and Rapid Medical Diagnostic Kits Market Detailed Analysis and Forecast by 2019 (NASDAQ:ABAX)
www.sbwire.com - September 30 at 3:09 PM
mysmartrend.com logoAbaxis Has Returned 17.8% Since SmarTrend Recommendation (ABAX) (NASDAQ:ABAX)
www.mysmartrend.com - September 24 at 3:10 PM
capitalcube.com logoABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : September 21, 2016 (NASDAQ:ABAX)
www.capitalcube.com - September 21 at 11:25 AM
capitalcube.com logoABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : September 20, 2016 (NASDAQ:ABAX)
www.capitalcube.com - September 20 at 3:03 PM
sbwire.com logoThe Top 100 U.S. in-Vitro Diagnostics Companies; New Report Launched (NASDAQ:ABAX)
www.sbwire.com - September 15 at 12:04 PM
streetinsider.com logoForm DEF 14A ABAXIS INC For: Oct 26 (NASDAQ:ABAX)
www.streetinsider.com - September 15 at 12:04 PM
News IconLearn details of the veterinary diagnostics market by products & technology (NASDAQ:ABAX)
www.whatech.com - September 10 at 8:00 AM
finance.yahoo.com logoAbaxis, Inc. to Present at the 7th Annual Credit Suisse Small & Mid Cap Conference (NASDAQ:ABAX)
finance.yahoo.com - September 8 at 12:12 PM
finance.yahoo.com logoAbaxis, Inc. to Present at the CL King 14th Annual Best Ideas Conference 2016 (NASDAQ:ABAX)
finance.yahoo.com - September 7 at 12:10 PM
News IconGlobal Veterinary Diagnostics Market 2016: Hospitals and Clinics, Reference Laboratories (NASDAQ:ABAX)
www.medgadget.com - September 6 at 8:00 AM
capitalcube.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : September 5, 2016 (NASDAQ:ABAX)
www.capitalcube.com - September 5 at 3:09 PM
newsmaker.com.au logoGlobal Veterinary Diagnostics Market 2016: Hospitals and Clinics, Reference Laboratories, Universities/Research Institutions, Point-of-care (NASDAQ:ABAX)
www.newsmaker.com.au - September 5 at 8:00 AM
einnews.com logoFarm Animal Diagnostics Market to Reach $4,215 million with 7.3% CAGR Forecast to 2022 (NASDAQ:ABAX)
world.einnews.com - September 3 at 3:03 PM
News IconPoint of Care (PoC) Lipid Test Market is Expected to Reach $280.02 Million by 2022 – Hexa Reports (NASDAQ:ABAX)
www.abnewswire.com - August 31 at 3:10 PM
4-traders.com logoABAXIS INC : ex-dividend day (NASDAQ:ABAX)
www.4-traders.com - August 29 at 8:22 PM
streetinsider.com logoForm 4 ABAXIS INC For: Aug 25 Filed by: SINGH PRITHIPAL (NASDAQ:ABAX)
www.streetinsider.com - August 26 at 11:19 AM
forbes.com logoEx-Dividend Reminder: Abaxis, McKesson and Universal Health Services (NASDAQ:ABAX)
www.forbes.com - August 26 at 11:19 AM
finance.yahoo.com logoAbaxis Hurt by Dismal Q1 Results & Fierce Competition (NASDAQ:ABAX)
finance.yahoo.com - August 26 at 11:19 AM
finance.yahoo.com logoNew Strong Sell Stocks for August 23rd (NASDAQ:ABAX)
finance.yahoo.com - August 23 at 3:00 PM
realistinvestor.com logoHere’s The Growth Forecast For ABAXIS, Inc. (NASDAQ:ABAX) (NASDAQ:ABAX)
www.realistinvestor.com - August 17 at 3:10 PM
finance.yahoo.com logoABAXIS INC Financials (NASDAQ:ABAX)
finance.yahoo.com - August 16 at 3:12 PM
News IconNorth America PoC Diagnostics Market Is Projected To Reach $8.95 Billion By 2024: Grand View Research, Inc. (NASDAQ:ABAX)
www.abnewswire.com - August 16 at 11:51 AM
finance.yahoo.com logoNew Strong Sell Stocks for August 15th (NASDAQ:ABAX)
finance.yahoo.com - August 15 at 10:28 AM
live-pr.com logo"Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:ABAX)
www.live-pr.com - August 11 at 9:05 PM
News IconNorth America PoC Diagnostics Market Worth $8.95 Billion By 2024 (NASDAQ:ABAX)
forextv.com - August 10 at 11:47 AM
News IconGlobal Companion Animal Diagnostics Market 2016 to grow at a CAGR of 8.84 % by 2022 : Market Research Store (NASDAQ:ABAX)
www.medgadget.com - August 5 at 11:34 AM
finance.yahoo.com logoNew Strong Sell Stocks for August 5th (NASDAQ:ABAX)
finance.yahoo.com - August 5 at 11:33 AM
finance.yahoo.com logoAbaxis, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference (NASDAQ:ABAX)
finance.yahoo.com - August 4 at 11:44 AM
News IconNew Study: 2016 Global Point-Of-Care Diagnostics / Testing (POCT) Market (NASDAQ:ABAX)
www.medgadget.com - July 29 at 3:06 PM
prnewswire.com logoVeterinary Diagnostics Market by Product by Technology by Animal - Global forecast to 2021 (NASDAQ:ABAX)
www.prnewswire.com - July 26 at 3:02 PM


Abaxis (NASDAQ:ABAX) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by MarketBeat.com Staff